HNMPA- (AM) 3
CAS: 120944-03-8
Ref. 3D-FH171943
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
Name:
HNMPA- (AM) 3
Description:
HNMPA-(AM) 3 is a potent inhibitor of tumor cell proliferation and an insulin sensitizing agent. It has been shown to inhibit the uptake of glucose by cancer cells, which may be due to its effect on insulin resistance. HNMPA- (AM) 3 also alters the signaling pathways in cancer cells, which leads to inhibition of tumor cell growth. This drug has been shown to prevent the differentiation of ventricular myocytes in culture and to reduce their viability by inhibiting protein synthesis and fatty acid metabolism. HNMPA- (AM) 3 also inhibits the cation channel that is present in L6 cells, leading to decreased cellular excitability. The effects of this drug are not limited to cancer cells as it can also affect other cell types such as PC12 cells.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
454.36 g/mol
Formula:
C20H23O10P
Purity:
Min. 95%
InChI:
InChI=1S/C20H23O10P/c1-14(21)25-11-28-20(19-9-8-17-6-4-5-7-18(17)10-19)31(24,29-12-26-15(2)22)30-13-27-16(3)23/h4-10,20H,11-13H2,1-3H3
InChI key:
InChIKey=UQODAZKXEREJLZ-UHFFFAOYSA-N
SMILES:
CC(=O)OCOC(c1ccc2ccccc2c1)P(=O)(OCOC(C)=O)OCOC(C)=O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
